{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:02:26Z","timestamp":1765609346917},"reference-count":33,"publisher":"Hindawi Limited","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2587,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress. Anxiety"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1002\/da.20403","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T15:12:40Z","timestamp":1193325160000},"page":"E18-E26","source":"Crossref","is-referenced-by-count":5,"title":["Cognitive style, alprazolam plasma levels, and treatment response in panic disorder"],"prefix":"10.1155","volume":"25","author":[{"given":"E.H.","family":"Uhlenhuth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladan","family":"Starcevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford","family":"Qualls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Antal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Matuzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javaid I.","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Barnhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1002\/da.20403-BIB1","doi-asserted-by":"crossref","unstructured":"Depression 10626417 15227162 1996 4 2","DOI":"10.1001\/archpsyc.1988.01800290027004"},{"key":"crKey-10.1002\/da.20403-BIB1","doi-asserted-by":"crossref","unstructured":"Anxiety 10709797 15227154 1996 2 5","DOI":"10.1001\/archpsyc.1988.01800290027004"},{"key":"crKey-10.1002\/da.20403-BIB2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment","volume":"45","author":"Ballenger","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.20403-BIB2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/00050060310001707217","article-title":"Cognitive effects of benzodiazepine use: a review","volume":"38","author":"Barker","year":"2003","journal-title":"Aust Psychologist"},{"key":"10.1002\/da.20403-BIB3","volume-title":"Cognitive therapy and the emotional disorders","author":"Beck","year":"1976"},{"key":"10.1002\/da.20403-BIB4","first-page":"31","volume-title":"Anxiety disorders and phobias: a cognitive perspective","author":"Beck","year":"1985"},{"key":"10.1002\/da.20403-BIB5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1176\/appi.ajp.160.8.1432","article-title":"Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?","volume":"160","author":"Bruce","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.20403-BIB6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1521\/bumc.65.1.58.18708","article-title":"Cognitive biases in anxiety disorders and their effect on cognitive-behavioral treatment","volume":"65","author":"Craske","year":"2001","journal-title":"Bull Menninger Clin"},{"key":"10.1002\/da.20403-BIB7","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-0327(86)90073-X","article-title":"Panic disorder, agoraphobia, and anxiety-relevant cognitive style","volume":"11","author":"Ganellen","year":"1986","journal-title":"J Affect Disord"},{"key":"10.1002\/da.20403-BIB8","first-page":"4","article-title":"Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications","volume":"54","author":"Greenblatt","year":"1993","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.20403-BIB9","volume-title":"ECDEU assessment manual for psychopharmacology, rev. 1976","author":"Guy","year":"1976"},{"key":"10.1002\/da.20403-BIB10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"20","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/da.20403-BIB11","first-page":"76","article-title":"Diagnosis and ratings of anxiety","volume":"3","author":"Hamilton","year":"1969","journal-title":"Br J Psychiatry"},{"key":"10.1002\/da.20403-BIB12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/bms.1200130306","article-title":"Quantitative analysis of alprazolam in human plasma by combined capillary gas chromatography\/negative ion chemical ionization mass spectrometry","volume":"13","author":"Javaid","year":"1986","journal-title":"Biomed Environ Mass Spect"},{"key":"10.1002\/da.20403-BIB13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0165-0327(02)00336-1","article-title":"Anxious Thoughts and Tendencies Scale: an investigation of factor structure and the psychometric properties on the basis of an Australian sample","volume":"79","author":"Khawaja","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1002\/da.20403-BIB14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1176\/ajp.119.5.432","article-title":"Psychiatric reaction patterns to imipramine","volume":"119","author":"Klein","year":"1962","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.20403-BIB15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archpsyc.1987.01800160093011","article-title":"Panic and avoidance in agoraphobia: application of path analysis to treatment studies","volume":"44","author":"Klein","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.20403-BIB16","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.296.10.1286","article-title":"Moderators of treatment outcomes. Clinical, research, and policy importance","volume":"296","author":"Kraemer","year":"2006","journal-title":"JAMA"},{"key":"10.1002\/da.20403-BIB17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00003088-199630010-00004","article-title":"Pharmacokinetic-pharmacodynamic relationships for benzodiazepines","volume":"30","author":"Laurijssens","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/da.20403-BIB18","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1176\/ajp.149.11.1556","article-title":"Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia","volume":"149","author":"Lesser","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.20403-BIB19","volume-title":"Neurobehavioral System 2 Users Manual, version 4.2","author":"Letz","year":"1988"},{"key":"10.1002\/da.20403-BIB20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0165-0327(79)90021-1","article-title":"The Hopkins Symptom Checklist (HSCL) - factors derived from the HSCL-90","volume":"1","author":"Lipman","year":"1979","journal-title":"J Affect Disord"},{"key":"10.1002\/da.20403-BIB21","volume-title":"Profile of mood states (manual)","author":"McNair","year":"1971"},{"key":"10.1002\/da.20403-BIB22","first-page":"1363","volume-title":"SAS\/STAT User's Guide, version 8.2","author":"SAS Institute, Inc","year":"1999"},{"key":"10.1002\/da.20403-BIB23","volume-title":"Instruction manual for the structured clinical interview for DSM-III-R, Upjohn Version (SCID-UP, 5\/1\/1988 revision)","author":"Spitzer","year":"1988"},{"key":"10.1002\/da.20403-BIB24","first-page":"31","article-title":"Growing placebo response rate: the problem in recent therapeutic trials?","volume":"33","author":"Uhlenhuth","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1002\/da.20403-BIB25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0165-0327(98)00061-5","article-title":"The revised Anxious Thoughts and Tendencies (AT&T) scale: a general measure of anxiety-prone cognitive style","volume":"52","author":"Uhlenhuth","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1002\/da.20403-BIB26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T","article-title":"International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997","volume":"9","author":"Uhlenhuth","year":"1999","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.20403-BIB27","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00004714-200012000-00007","article-title":"Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication","volume":"20","author":"Uhlenhuth","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.20403-BIB28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0165-0327(01)00457-8","article-title":"A general anxiety-prone cognitive style in anxiety disorders","volume":"70","author":"Uhlenhuth","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1002\/da.20403-BIB29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00004714-200206000-00008","article-title":"Interactive model of therapeutic response in panic disorder: moclobemide, a case in point","volume":"22","author":"Uhlenhuth","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.20403-BIB30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.jcp.0000236653.85791.60","article-title":"Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs","volume":"26","author":"Uhlenhuth","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.20403-BIB31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2005.12.036","article-title":"Psychopathology of panic attacks in panic disorder","volume":"92","author":"Uhlenhuth","year":"2006","journal-title":"J Affect Disord"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.20403","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/da.20403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:02:59Z","timestamp":1671541379000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.20403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"URL":"https:\/\/doi.org\/10.1002\/da.20403","relation":{},"ISSN":["1091-4269","1520-6394"],"issn-type":[{"value":"1091-4269","type":"print"},{"value":"1520-6394","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}